Diagnosis and Management of Esophageal Fistulas After Lung Transplantation : A Case Series
Copyright © 2024 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc..
Background: Lung transplantations are highly complex procedures, often conducted in frail patients. Through the addition of immunosuppressants, healing can be compromised, primarily leading to the development of bronchopleural fistulas. Although esophageal fistulas (EFs) after lung transplantation remain rare, they are associated with significant morbidity. We aimed to investigate the clinical presentation, diagnostic approaches, and treatment strategies of EF after lung transplantation.
Methods: All patients who developed EF after lung transplantation at the University Hospitals Leuven between January 2019 and March 2022 were retrospectively reviewed and the clinical presentations, diagnostic approaches, and treatment strategies were summarized.
Results: Among 212 lung transplantation patients, 5 patients (2.4%) developed EF. Three patients were male and median age was 39 y (range, 34-63). Intraoperative circulatory support was required in 3 patients, with 2 needing continued support postoperatively. Bipolar energy devices were consistently used for mediastinal hemostasis. All EFs were right-sided. Median time to diagnosis was 28 d (range, 12-48) and 80% of EFs presented as recurrent respiratory infections or empyema. Diagnosis was made through computed tomography (n = 3) or esophagogastroscopy (n = 2). Surgical repair with muscle flap covering achieved an 80% success rate. All patients achieved complete resolution, with only 1 patient experiencing a fatal outcome during a complicated EF-related recovery.
Conclusion: Although EF after lung transplantation remains rare, vigilance is crucial, particularly in cases of right-sided intrathoracic infection. Moreover, caution must be exercised when applying thermal energy in the mediastinal area to prevent EF development and mitigate the risk of major morbidity. Timely diagnosis and surgical intervention can yield favorable outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Transplantation direct - 10(2024), 3 vom: 15. Feb., Seite e1593 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vanstraelen, Stijn [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 29.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1097/TXD.0000000000001593 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369049047 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369049047 | ||
| 003 | DE-627 | ||
| 005 | 20240229235453.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/TXD.0000000000001593 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM369049047 | ||
| 035 | |a (NLM)38414977 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vanstraelen, Stijn |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnosis and Management of Esophageal Fistulas After Lung Transplantation |b A Case Series |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. | ||
| 520 | |a Background: Lung transplantations are highly complex procedures, often conducted in frail patients. Through the addition of immunosuppressants, healing can be compromised, primarily leading to the development of bronchopleural fistulas. Although esophageal fistulas (EFs) after lung transplantation remain rare, they are associated with significant morbidity. We aimed to investigate the clinical presentation, diagnostic approaches, and treatment strategies of EF after lung transplantation | ||
| 520 | |a Methods: All patients who developed EF after lung transplantation at the University Hospitals Leuven between January 2019 and March 2022 were retrospectively reviewed and the clinical presentations, diagnostic approaches, and treatment strategies were summarized | ||
| 520 | |a Results: Among 212 lung transplantation patients, 5 patients (2.4%) developed EF. Three patients were male and median age was 39 y (range, 34-63). Intraoperative circulatory support was required in 3 patients, with 2 needing continued support postoperatively. Bipolar energy devices were consistently used for mediastinal hemostasis. All EFs were right-sided. Median time to diagnosis was 28 d (range, 12-48) and 80% of EFs presented as recurrent respiratory infections or empyema. Diagnosis was made through computed tomography (n = 3) or esophagogastroscopy (n = 2). Surgical repair with muscle flap covering achieved an 80% success rate. All patients achieved complete resolution, with only 1 patient experiencing a fatal outcome during a complicated EF-related recovery | ||
| 520 | |a Conclusion: Although EF after lung transplantation remains rare, vigilance is crucial, particularly in cases of right-sided intrathoracic infection. Moreover, caution must be exercised when applying thermal energy in the mediastinal area to prevent EF development and mitigate the risk of major morbidity. Timely diagnosis and surgical intervention can yield favorable outcomes | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Vos, Robin |e verfasserin |4 aut | |
| 700 | 1 | |a Dausy, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Van Slambrouck, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Vanluyten, Cedric |e verfasserin |4 aut | |
| 700 | 1 | |a De Leyn, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Coosemans, Willy |e verfasserin |4 aut | |
| 700 | 1 | |a Decaluwé, Herbert |e verfasserin |4 aut | |
| 700 | 1 | |a Van Veer, Hans |e verfasserin |4 aut | |
| 700 | 1 | |a Depypere, Lieven |e verfasserin |4 aut | |
| 700 | 1 | |a Bisschops, Raf |e verfasserin |4 aut | |
| 700 | 1 | |a Demedts, Ingrid |e verfasserin |4 aut | |
| 700 | 1 | |a Casaer, Michael P |e verfasserin |4 aut | |
| 700 | 1 | |a Debaveye, Yves |e verfasserin |4 aut | |
| 700 | 1 | |a De Vlieger, Greet |e verfasserin |4 aut | |
| 700 | 1 | |a Godinas, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Verleden, Geert |e verfasserin |4 aut | |
| 700 | 1 | |a Van Raemdonck, Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Nafteux, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Ceulemans, Laurens J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transplantation direct |d 2015 |g 10(2024), 3 vom: 15. Feb., Seite e1593 |w (DE-627)NLM249149893 |x 2373-8731 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g number:3 |g day:15 |g month:02 |g pages:e1593 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/TXD.0000000000001593 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |e 3 |b 15 |c 02 |h e1593 | ||